Abstract:Candia auris is an emerging human pathogenic yeast; yet, despite phenotypic attributes and genomic evidence suggesting that it probably emerged from a natural reservoir, we know nothing about the environmental phase of its life cycle and the transmission pathways associated with it. The thermotolerant characteristics of C . auris have been hypothesised to be an environmental adaptation to increasing temperatures due to global warming (which may have facilitated its ability to tolerate the mammalian thermal barrier that is considered a protective strategy for humans against colonisation by environmental fungi with pathogenic potential). Thus, C . auris may be the first human pathogenic fungus to have emerged as a result of climate change. In addition, the release of antifungal chemicals, such as azoles, into the environment (from both pharmaceutical and agricultural sources) is likely to be responsible for the environmental enrichment of resistant strains of C . auris ; however, the survival and dissemination of C . auris in the natural environment is poorly understood. In this paper, we critically review the possible pathways through which C . auris can be introduced into the environment and evaluate the environmental characteristics that can influence its persistence and transmission in natural environments. Identifying potential environmental niches and reservoirs of C . auris and understanding its emergence against a backdrop of climate change and environmental pollution will be crucial for the development of effective epidemiological and environmental management responses. The natural environment can play a significant role in the epidemiology of infectious diseases as pathogens persist and evolve in environmental niches from where they can be transferred to new hosts. Therefore, understanding the interaction of pathogens with potential environmental reservoirs is crucial to the control of pathogenic diseases. Pathogenic Candida species have been widely isolated from nonclinical environmental sources such as soil, freshwater, seawater, and animals such as birds. The persistence and dissemination of C . auris , a recently emerged human pathogenic yeast, in the environment is still poorly understood. Here, we identify the potential pathways through which C . auris can be introduced into the natural environment and the characteristics that can influence its survival in various environmental matrices. In conclusion, we review the current knowledge gaps and identify the future research needed to understand the epidemiological implications of C . auris in the natural environment.

Epidemiology Update and a Review of Strategies to Prevent Spread

Candida auris: A focused review for emergency clinicians

Candida Auris: Epidemiology, Biology, Antifungal Resistance, and Virulence.

The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England

Candida auris as a pathogen that can cause emerging infectious disease: a literature review

Current Perspectives of Antifungal Therapy: A Special Focus on Candida auris

Candida auris-a systematic review to inform the world health organization fungal priority pathogens list

Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic

Candida auris and COVID-19: A health threatening combination

Pathogenesis, Prophylaxis, and Treatment of Candida auris

Current global status of Candida auris an emerging multidrug-resistant fungal pathogen: bibliometric analysis and network visualization

Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida auris

Candida auris infection; diagnosis, and resistance mechanism using high-throughput sequencing technology: a case report and literature review

Impact of the COVID-19 Pandemic on Candida auris Infections: A Retrospective Analysis in an Academic Medical Center in New York City

Candida auris Updates: Outbreak Evaluation through Molecular Assays and Antifungal Stewardship—A Narrative Review

Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory

Candida auris infections in China

Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?

Navigating the Challenges of Candida auris Colonization in Rehabilitation Settings

Prevalence and Outcomes of Candida auris Infections in a Tertiary Hospital in the United Arab Emirates (UAE)

Environmental reservoirs of the drug-resistant pathogenic yeast Candida auris